Oxford Centre for Diabetes Endocrinology and Metabolism (OCDEM), Oxford, UK.
Curr Genomics. 2011 Dec;12(8):526-41. doi: 10.2174/138920211798120790.
The autoimmune thyroid diseases (AITD) include Graves' disease (GD) and Hashimoto's thyroiditis (HT), which are characterised by a breakdown in immune tolerance to thyroid antigens. Unravelling the genetic architecture of AITD is vital to better understanding of AITD pathogenesis, required to advance therapeutic options in both disease management and prevention. The early whole-genome linkage and candidate gene association studies provided the first evidence that the HLA region and CTLA-4 represented AITD risk loci. Recent improvements in; high throughput genotyping technologies, collection of larger disease cohorts and cataloguing of genome-scale variation have facilitated genome-wide association studies and more thorough screening of candidate gene regions. This has allowed identification of many novel AITD risk genes and more detailed association mapping. The growing number of confirmed AITD susceptibility loci, implicates a number of putative disease mechanisms most of which are tightly linked with aspects of immune system function. The unprecedented advances in genetic study will allow future studies to identify further novel disease risk genes and to identify aetiological variants within specific gene regions, which will undoubtedly lead to a better understanding of AITD patho-physiology.
自身免疫性甲状腺疾病(AITD)包括格雷夫斯病(GD)和桥本甲状腺炎(HT),其特征是对甲状腺抗原的免疫耐受破裂。揭示 AITD 的遗传结构对于更好地了解 AITD 的发病机制至关重要,这对于疾病管理和预防中的治疗选择的推进是必需的。早期的全基因组连锁和候选基因关联研究首次提供了证据,表明 HLA 区域和 CTLA-4 代表 AITD 风险位点。高通量基因分型技术的最新进展、更大的疾病队列的收集以及全基因组变异的编目,促进了全基因组关联研究和对候选基因区域的更全面筛选。这使得许多新的 AITD 风险基因的鉴定和更详细的关联图谱成为可能。越来越多的已确认的 AITD 易感性位点表明存在许多假定的疾病机制,其中大多数与免疫系统功能的各个方面紧密相关。遗传研究的空前进展将使未来的研究能够进一步确定新的疾病风险基因,并确定特定基因区域内的病因变体,这无疑将导致对 AITD 病理生理学的更好理解。